查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529834

全球動物骨科生物技術市場：市場規模、佔有率、趨勢分析 - 按交付模式、按產品、按動物、按應用、按最終用途、按地區、細分市場預測，2024-2030 年

Veterinary Orthobiologics Market Size, Share & Trends Analysis Report By Mode of Delivery (Intra-muscular/Intra-lesional, Intra-articular), By Product, By Animal, By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

動物骨科生物技術市場成長與趨勢：

預計2030年全球動物骨科生物技術市場規模將達12.4億美元，2024年至2030年複合年成長率為8.82%。

推動市場成長的兩個關鍵因素是骨科生物技術臨床試驗數量的增加和動物整形外科併發症盛行率的上升。近年來，該行業用於治療獸醫整形外科併發症的新型骨科生物製藥的臨床試驗穩步增加。例如，2024年6月，美國FDA核准在狗和馬身上啟動幹細胞臨床試驗。此臨床試驗將由康乃爾大學動物醫院（CUHA）進行。這項研究探討了幹細胞在治療狗和馬的神經和肌肉骨骼併發症的有效性。研究將從參與者的同基因脂肪或骨髓中提取間質幹細胞，並用它們來治療神經、肌肉和其他疾病。

這項研究收集的資料將有助於獸醫再生醫學臨床實證產品的開發。此外，細胞治療工具也於2024年6月開始臨床試驗。在臨床前研究中，該公司的產品 ClondroShield 對參與的狗反應良好，顯示 OA 得到改善，且沒有副作用。這一最新的臨床試驗階段旨在招募更多的犬類參與者進行進一步的試驗。該產品利用狗血小板內的細胞激素和生長因子來觸發受影響區域的癒合反應並幫助修復軟骨。這種持續的進步表明市場正在不斷發展並帶來許多成長機會。此類研究正在幫助開發基於經過徹底審查的證據來治療整形外科疾病的新產品，為市場提供了顯著的成長前景。

此外，整形外科疾病在世界各地的動物中變得越來越常見。例如，在 2024 年發表在 Plos One 上的一項研究中，幾位研究人員合作啟動了“狗老化計劃”，並成功繪製和了解了狗整個生命週期的疾病模式。該計劃發現，如果不及時治療，整形外科疾病的盛行率會隨著狗的年齡增加而增加。此外，體重30公斤或以上的狗整形外科疾病盛行率較高（23%），顯示肥胖與整形外科疾病之間存在相關性。此外，根據 NCBI 2023 年發表的一篇論文，貓骨關節炎 (OA) 的盛行率估計約為 60%。據報道，被診斷患有骨關節炎的人會出現關節疼痛、關節畸形和跛行等相關症狀。事實證明，這些症狀在超重的貓中更為常見。所有這些因素意味著需要適當的生物製藥，如幹細胞、富血小板血漿 (PRP) 和單株抗體 (mAb) 來治療越來越多的動物整形外科併發症。

動物骨科生物技術市場報告亮點

  • 2023 年，PRP 產品部門的收益佔有率最大，為 39.2%。在動物中，血小板對於免疫反應、血管生成和組織修復等多種過程至關重要。 PRP 用於促進血液凝固的癒合過程，因為它含有蛋白質和生長因子，可透過加速新組織的生長來加速肌腱和韌帶的癒合。
  • 犬科動物細分市場的特徵是採用率高、狗運動相關損傷病例增加、狗骨關節炎患病率高（40%）以及五分之一的狗跛行（Zoetis，2024 年資料），2023 年，該領域佔主導地位。
  • 由於狗、貓和馬的 OA 盛行率較高以及 OA 的影響因素不斷增加，OA 應用領域將在 2023 年以超過 60% 的佔有率佔據市場主導地位。 OA 正成為動物最常見的疾病之一。 OA的主要致病因素包括肥胖、品種、缺乏運動和適當飲食以及遺傳傾向。
  • 2023年，市場將由關節內給藥模式細分市場主導。這一優勢是由於其高需求，因為直接關節內給藥可以實現更快的作用並提高藥物的生物有效性。在獸醫學中，關節內施用關節生物製藥是治療關節疼痛和跛行的既定方法。
  • 根據最終用途，由於在獸醫診所接受動物整形外科疾病治療的患者數量不斷增加，獸醫診所細分市場將在 2023 年佔據市場佔有率主導地位。在需要時，特定的設備和熟練的人員對於管理生物製藥至關重要。總體而言，在醫院藥房的一個地方獲得治療方法、熟練的員工和專業設備對動物飼主來說是一項優勢。
  • 北美地區佔比最大，2023年為43.23%。這一優勢是由於寵物擁有量高、飼主對動物健康的認知高、動物健康支出增加以及 Zoetis、VetStem Inc.、Enso Discovery 和 Ardent Animal Health 等大公司的存在。
  • 由於日本、中國和印度等主要國家研發活動的獨創性不斷增強，亞太市場預計從 2024 年到 2030 年將以超過 10.09% 的最高複合年成長率成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章動物骨科生物技術市場波動趨勢及範圍

  • 市場體系展望
  • 市場動態
  • 動物骨科生物技術市場分析工具

第4章動物骨科生物技術市場：產品評估與趨勢分析

  • 細分儀表板
  • 動物骨科生物技術市場：產品變異分析
  • 2018-2030年動物骨科生物技術市場規模與趨勢分析（依產品）
  • 幹細胞
  • 富血小板血漿 (PRP)
  • 其他生技藥品

第5章動物骨科生物技術市場：動物估計與趨勢分析

  • 細分儀表板
  • 動物骨科生物技術市場：動物變異分析
  • 2018-2030年動物骨科生物技術市場規模與趨勢分析（依動物）
  • 狗
  • 馬
  • 其他

第6章動物骨科生物技術市場：應用估算與趨勢分析

  • 細分儀表板
  • 動物骨科生物技術市場：應用變化分析
  • 2018-2030年動物骨科生物技術市場規模與趨勢分析（按應用）
  • 骨關節炎
  • 骨關節炎
  • 其他用途

第7章動物骨科生物技術市場：交付模式的估計和趨勢分析

  • 細分儀表板
  • 動物骨科生物技術市場：分娩方式的變化分析
  • 2018-2030年動物骨科生物技術市場規模及趨勢分析（依交付模式）

第8章動物骨科生物技術市場：最終用途估計和趨勢分析

  • 細分儀表板
  • 動物骨科生物技術市場：最終用途變化分析
  • 2018-2030 年動物骨科生物技術市場規模與趨勢分析（依最終用途）

第9章動物骨科生物技術市場：區域估計和趨勢分析

  • 區域儀表板
  • 2023 年和 2030 年按地區分類的動物骨科生物技術市場佔有率，百萬美元
  • 區域展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭格局

  • 市場參與企業分類
  • 企業市場分析/堆圖分析
  • 公司簡介
    • Zoetis
    • Boehringer Ingelheim
    • Ardent Animal Health Llc.
    • Enso Discoveries
    • VetStem Inc.
    • Medrego Llc
    • T-Cyte Therapeutics
    • Arthrex Inc.
    • Hilltop Bio
    • Enovis
    • Movora
    • Dechra Pharmaceuticals Llc.
  • 策略規劃
    • 併購
    • 夥伴關係與協作
    • 擴張
    • 產品發布
    • 產品核可
    • 其他
  • 主要企業名單
  • 製造商清單
    • 經銷商名單
Product Code: GVR-4-68040-369-5

Veterinary Orthobiologics Market Growth & Trends:

The global veterinary orthobiologics market size is expected to reach USD 1.24 billion by 2030, registering a CAGR of 8.82% from 2024 to 2030, according to a new report by Grand View Research, Inc. Two crucial factors driving the market growth are the increasing number of clinical trials in orthobiologics and the rising prevalence of orthopedic complications in animals. The industry has experienced a steady rise in clinical trials for novel orthobiologics in treating veterinary orthopedic complications in recent years. For instance, in June 2024, the U.S. FDA approved initiating stem cell clinical trials for dogs & horses. This trial will be conducted by Cornell University Hospital for Animals (CUHA). It will explore the effectiveness of stem cells in treating neurological and musculoskeletal complications in canine & equine species. The study will extract the participants' allogenic adipose or bone marrow-derived mesenchymal stem cells and use them to treat nerve, muscle, and other conditions.

The data gathered from this study will help develop clinical evidence-based products in veterinary regenerative medicine. Furthermore, Cell Therapy Tools initiated another clinical trial in June 2024. In the pre-clinical studies, the company's product, Chrondroshield, the participants' dogs responded well to the therapy, showing improvements in OA without side effects. This latest clinical trial phase aims to recruit more canine participants for further testing. This product uses cytokine and growth factors inside the dog's platelets to trigger a healing response in the affected area and assist in cartilage repair. These ongoing advancements showcase the market's ever-evolving nature, with many growth opportunities. Studies like these help create novel products for treating orthopedic conditions with a thoroughly scrutinized base of evidence, providing the market with substantial growth prospects.

In addition, throughout the globe, orthopedic conditions are becoming increasingly common in animals. For instance, according to a 2024 Plos One published study, multiple researchers collaborated to initiate a "Dog Aging Project" to map out and understand disease patterns in dogs throughout their lives. The project determined that the prevalence of orthopedic conditions, if left untreated, increases as the age of the dogs progresses, i.e., prevalence at age 1 - 1% and prevalence at age 11 & above - 39%. The dogs with higher weight, i.e., more than 30 kgs, were determined to have a higher prevalence of orthopedic conditions (23%), thus establishing a correlation between obesity and orthopedic diseases. Furthermore, according to a 2023 publication in NCBI, the prevalence of Osteoarthritis (OA) in cats was estimated at around 60%. Those diagnosed with OA were reported to be suffering from associated conditions, such as joint pain, joint deformity, lameness, etc. These symptoms were determined to be on the higher side in overweight cats. All these factors collectively point toward the need for appropriate orthobiologics like stem cells, platelet-rich plasma (PRP), and monoclonal antibody (mAb) to treat this rise in orthopedic complications in animals.

Veterinary Orthobiologics Market Report Highlights:

  • The PRP product segment accounted for the largest revenue share of 39.2% in 2023. In animals, platelets are vital in multiple processes, such as immune response, angiogenesis, and tissue repair. PRP is employed to promote the healing process in blood clotting as it contains proteins & growth factors that speed up the healing of the tendons & ligaments by speeding up the growth of new tissues
  • The canine animal segment dominated the market with a share of 46.1% in 2023 due to the high adoption rate, rising cases of sports-related injuries in dogs, and high prevalence of OA in dogs (40%) and lameness in 1 in 5 dogs (Zoetis, 2024 data)
  • The OA application segment dominated the market with a share of over 60% in 2023 because of the high prevalence of OA and rise in contributing factors to OA in dogs, cats, and horses. OA is becoming one of the most prevalent conditions in animals. The main causative factors for OA can be obesity, breed, lack of exercise & proper diet, and genetic predisposition
  • The intra-articular delivery mode segment dominated the market in 2023. This dominance can be attributed to its demand as it can be directly delivered into the joint to ensure faster action and increase drug bioavailability. In veterinary medicine, intra-articular administration of orthobiologics is an established process for managing joint pain and lameness
  • Based on the end use, the veterinary hospitals segment dominated the market in terms of share in 2023 due to the increased number of patients receiving treatment for orthopedic medical conditions in animals at these hospitals. To administer orthobiologics at the necessary location, specific equipment and skilled staff are essential. Overall, the availability of therapies, skilled personnel, and specialized equipment at the hospital pharmacy in a single location is advantageous to animal owners
  • North America accounted for the largest share of 43.23% in 2023. This dominance can be attributed to the high pet adoption rate, higher animal health awareness among owners, rising spending on animal health, and the presence of major companies, such as Zoetis, VetStem Inc., Enso Discoveries, and Ardent Animal Health
  • The Asia Pacific APAC regional market is expected to grow at the highest CAGR of over 10.09% from 2024 to 2030 due to increasing ingenuity in R&D activities in major countries like Japan, China, and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Orthobiologics Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advances in Veterinary Regenerative Medicine
      • 3.2.1.2. Rising Prevalence of Orthopedic Complications in Animals
      • 3.2.1.3. Global Rise in Animal Athletic Events
      • 3.2.1.4. Rising Innovative Product Launches
      • 3.2.1.5. Increasing Number of Clinical Trials
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Underdiagnosis of Orthopedic Complications
      • 3.2.2.2. Misleading Practices by Industry Players
      • 3.2.2.3. Product Limitations
      • 3.2.2.4. Lack of Clinical Evidence
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Orthobiologics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Estimated Animal Population, by Key Species, by Key Countries, 2018-2023
    • 3.3.5. Clinical Trials Analysis
    • 3.3.6. Pricing Analysis
    • 3.3.7. COVID-19 Impact Analysis

Chapter 4. Veterinary Orthobiologics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Orthobiologics Market: Product Movement Analysis
  • 4.3. Veterinary Orthobiologics Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
  • 4.4. Stem Cells
    • 4.4.1. Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Platelet-Rich Plasma (PRP)
    • 4.5.1. Platelet-Rich Plasma (PRP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Other Biologics
    • 4.6.1. Other Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Orthobiologics Market: Animal Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Orthobiologics Market: Animal Movement Analysis
  • 5.3. Veterinary Orthobiologics Market Size & Trend Analysis, by animal, 2018 to 2030 (USD Million)
  • 5.4. Canine
    • 5.4.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Equine
    • 5.5.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Orthobiologics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Orthobiologics Market: Application Movement Analysis
  • 6.3. Veterinary Orthobiologics Market Size & Trend Analysis, by application, 2018 to 2030 (USD Million)
  • 6.4. Osteoarthritis
    • 6.4.1. Osteoarthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Degenerative Joint Disease
    • 6.5.1. Degenerative Joint Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Other Applications
    • 6.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Orthobiologics Market: By Mode of Delivery Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary Orthobiologics Market: By Mode of Delivery Movement Analysis
  • 7.3. Veterinary Orthobiologics Market Size & Trend Analysis, by mode of delivery, 2018 to 2030 (USD Million)
    • 7.3.1. Intra-muscular/Intra-lesional
      • 7.3.1.1. Intra-muscular/Intra-lesional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Intra-articular
      • 7.3.2.1. Intra-articular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Other Modes
      • 7.3.3.1. Other Modes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Orthobiologics Market: By End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Veterinary Orthobiologics Market: By End Use Movement Analysis
  • 8.3. Veterinary Orthobiologics Market Size & Trend Analysis, by end use, 2018 to 2030 (USD Million)
    • 8.3.1. Veterinary Hospitals
      • 8.3.1.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. Veterinary Clinics
      • 8.3.2.1. Veterinary Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Others
      • 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Veterinary Orthobiologics Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Veterinary Orthobiologics Market Share, By Region, 2023 & 2030, USD Million
  • 9.3. Regional Outlook
  • 9.4. North America
    • 9.4.1. North America Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competition Insights
      • 9.4.2.3. U.S. Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competition Insights
      • 9.4.3.3. Canada Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competition Insights
      • 9.4.4.3. Mexico Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competition Insights
      • 9.5.2.3. UK Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competition Insights
      • 9.5.3.3. Germany Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competition Insights
      • 9.5.4.3. France Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competition Insights
      • 9.5.5.3. Italy Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competition Insights
      • 9.5.6.3. Spain Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. Denmark
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competition Insights
      • 9.5.7.3. Denmark Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Competition Insights
      • 9.5.8.3. Sweden Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.9. Norway
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Competition Insights
      • 9.5.9.3. Norway Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competition Insights
      • 9.6.2.3. Japan Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competition Insights
      • 9.6.3.3. China Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competition Insights
      • 9.6.4.3. India Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Competition Insights
      • 9.6.5.3. Australia Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Competition Insights
      • 9.6.6.3. South Korea Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Competition Insights
      • 9.6.7.3. Thailand Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competition Insights
      • 9.7.2.3. Brazil Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competition Insights
      • 9.7.3.3. Argentina Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8. Middle East & Africa
    • 9.8.1. Middle East & Africa Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Competition Insights
      • 9.8.2.3. South Africa Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Competition Insights
      • 9.8.3.3. Saudi Arabia Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Competition Insights
      • 9.8.4.3. UAE Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Competition Insights
      • 9.8.5.3. Kuwait Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Company Market Position Analysis/ Heap Map Analysis
  • 10.3. Company Profiles
    • 10.3.1. Zoetis
      • 10.3.1.1. Participant's Overview
      • 10.3.1.2. Financial Performance
      • 10.3.1.3. Product Benchmarking
      • 10.3.1.4. Strategic Initiatives
    • 10.3.2. Boehringer Ingelheim
      • 10.3.2.1. Participant's Overview
      • 10.3.2.2. Financial Performance
      • 10.3.2.3. Product Benchmarking
      • 10.3.2.4. Strategic Initiatives
    • 10.3.3. Ardent Animal Health Llc.
      • 10.3.3.1. Participant's Overview
      • 10.3.3.2. Financial Performance
      • 10.3.3.3. Product Benchmarking
      • 10.3.3.4. Strategic Initiatives
    • 10.3.4. Enso Discoveries
      • 10.3.4.1. Participant's Overview
      • 10.3.4.2. Financial Performance
      • 10.3.4.3. Product Benchmarking
      • 10.3.4.4. Strategic Initiatives
    • 10.3.5. VetStem Inc.
      • 10.3.5.1. Participant's Overview
      • 10.3.5.2. Financial Performance
      • 10.3.5.3. Product Benchmarking
      • 10.3.5.4. Strategic Initiatives
    • 10.3.6. Medrego Llc
      • 10.3.6.1. Participant's Overview
      • 10.3.6.2. Financial Performance
      • 10.3.6.3. Product Benchmarking
      • 10.3.6.4. Strategic Initiatives
    • 10.3.7. T-Cyte Therapeutics
      • 10.3.7.1. Participant's Overview
      • 10.3.7.2. Financial Performance
      • 10.3.7.3. Product Benchmarking
      • 10.3.7.4. Strategic Initiatives
    • 10.3.8. Arthrex Inc.
      • 10.3.8.1. Participant's Overview
      • 10.3.8.2. Financial Performance
      • 10.3.8.3. Product Benchmarking
      • 10.3.8.4. Strategic Initiatives
    • 10.3.9. Hilltop Bio
      • 10.3.9.1. Participant's Overview
      • 10.3.9.2. Financial Performance
      • 10.3.9.3. Product Benchmarking
      • 10.3.9.4. Strategic Initiatives
    • 10.3.10. Enovis
      • 10.3.10.1. Participant's Overview
      • 10.3.10.2. Financial Performance
      • 10.3.10.3. Product Benchmarking
      • 10.3.10.4. Strategic Initiatives
    • 10.3.11. Movora
      • 10.3.11.1. Participant's Overview
      • 10.3.11.2. Financial Performance
      • 10.3.11.3. Product Benchmarking
      • 10.3.11.4. Strategic Initiatives
    • 10.3.12. Dechra Pharmaceuticals Llc.
      • 10.3.12.1. Participant's Overview
      • 10.3.12.2. Financial Performance
      • 10.3.12.3. Product Benchmarking
      • 10.3.12.4. Strategic Initiatives
  • 10.4. Strategy Mapping
    • 10.4.1. Mergers & Acquisitions
    • 10.4.2. Partnerships & Collaborations
    • 10.4.3. Expansion
    • 10.4.4. Product launch
    • 10.4.5. Product Approval
    • 10.4.6. Others
  • 10.5. List of Key Companies
  • 10.6. List of Manufacturers
    • 10.6.1. List of Distributors

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 Global Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 5 Global Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 6 Global Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 7 Global Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 Global Veterinary Orthobiologics Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 North America Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 12 North America Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 North America Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 14 North America Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 U.S. Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 16 U.S. Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 17 U.S. Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 18 U.S. Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 19 U.S. Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20 Canada Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Canada Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 22 Canada Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Canada Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 24 Canada Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 Mexico Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 Mexico Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 27 Mexico Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 28 Mexico Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 29 Mexico Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30 Europe Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Europe Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 33 Europe Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 34 Europe Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 35 Europe Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 36 Germany Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 37 Germany Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 38 Germany Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Germany Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 40 Germany Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41 UK Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 UK Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 43 UK Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 UK Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 45 UK Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 France Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 France Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 48 France Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 France Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 50 France Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51 Italy Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 52 Italy Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 53 Italy Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 Italy Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 55 Italy Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 Spain Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 57 Spain Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 58 Spain Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 59 Spain Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 60 Spain Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 Denmark Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 62 Denmark Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 63 Denmark Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Denmark Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 65 Denmark Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66 Sweden Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 67 Sweden Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 68 Sweden Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 Sweden Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 70 Sweden Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 71 Norway Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 72 Norway Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 73 Norway Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Norway Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 75 Norway Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82 China Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 83 China Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 84 China Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 85 China Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 86 China Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 87 Japan Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 88 Japan Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 89 Japan Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 Japan Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 91 Japan Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 92 India Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 93 India Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 94 India Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 India Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 96 India Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 97 South Korea Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 98 South Korea Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 99 South Korea Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 100 South Korea Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 101 South Korea Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 102 Australia Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 103 Australia Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 104 Australia Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 105 Australia Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 106 Australia Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 107 Thailand Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 108 Thailand Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 109 Thailand Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 110 Thailand Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 111 Thailand Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 112 Latin America Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
  • Table 113 Latin America Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 114 Latin America Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 115 Latin America Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 116 Latin America Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 117 Latin America Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 118 Brazil Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 119 Brazil Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 120 Brazil Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 121 Brazil Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 122 Brazil Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 123 Argentina Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 124 Argentina Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 125 Argentina Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 126 Argentina Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 127 Argentina Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 134 South Africa Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 135 South Africa Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 136 South Africa Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 137 South Africa Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 138 South Africa Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 144 UAE Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 145 UAE Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 146 UAE Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 147 UAE Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 148 UAE Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Veterinary Orthobiologics Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Veterinary Orthobiologics Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 15 Global Veterinary Orthobiologics Market, for Stem Cells, 2018 - 2030 (USD Million)
  • Fig. 16 Global Veterinary Orthobiologics Market, for Platelet-Rich Plasma (PRP), 2018 - 2030 (USD Million)
  • Fig. 17 Global Veterinary Orthobiologics Market, for Other Biologics, 2018 - 2030 (USD Million)
  • Fig. 18 Global Veterinary Orthobiologics Market, for Animal, 2018 - 2030 (USD Million)
  • Fig. 19 Global Veterinary Orthobiologics Market, for Canine, 2018 - 2030 (USD Million)
  • Fig. 20 Global Veterinary Orthobiologics Market, for Equine, 2018 - 2030 (USD Million)
  • Fig. 21 Global Veterinary Orthobiologics Market, for Other Animals, 2018 - 2030 (USD Million)
  • Fig. 22 Global Veterinary Orthobiologics Market, for Application, 2018 - 2030 (USD Million)
  • Fig. 23 Global Veterinary Orthobiologics Market, for Osteoarthritis, 2018 - 2030 (USD Million)
  • Fig. 24 Global Veterinary Orthobiologics Market, for Degenerative Joint Disease (DJD), 2018 - 2030 (USD Million)
  • Fig. 25 Global Veterinary Orthobiologics Market, for Other Applications, 2018 - 2030 (USD Million)
  • Fig. 26 Global Veterinary Orthobiologics Market, for Mode of Delivery, 2018 - 2030 (USD Million)
  • Fig. 27 Global Veterinary Orthobiologics Market, for Intra-muscular/Intra-lesional, 2018 - 2030 (USD Million)
  • Fig. 28 Global Veterinary Orthobiologics Market, for Intra-articular, 2018 - 2030 (USD Million)
  • Fig. 29 Global Veterinary Orthobiologics Market, for Other Modes, 2018 - 2030 (USD Million)
  • Fig. 30 Global Veterinary Orthobiologics Market, for End Use, 2018 - 2030 (USD Million)
  • Fig. 31 Global Veterinary Orthobiologics Market, for Veterinary Hospitals, 2018 - 2030 (USD Million)
  • Fig. 32 Global Veterinary Orthobiologics Market, for Veterinary Clinics, 2018 - 2030 (USD Million)
  • Fig. 33 Global Veterinary Orthobiologics Market, for Other end-use, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Outlook, 2023 & 2030
  • Fig. 35 North America Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 47 NorwayVeterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 50 China Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 51 India Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)